Cargando…
The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers
INTRODUCTION: The cannabinoid CB1 receptor (CB1R) has been shown in preclinical studies to be involved in nicotine reinforcement and relapse‐like behavior. The common single nucleotide polymorphism (SNP) rs2023239 may code for an alternative CB1R protein, alter CB1R expression, and be involved in ni...
Autores principales: | Chukwueke, Chidera C., Kowalczyk, William J., Gendy, Marie, Taylor, Richard, Tyndale, Rachel F., Le Foll, Bernard, Heishman, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882168/ https://www.ncbi.nlm.nih.gov/pubmed/33369277 http://dx.doi.org/10.1002/brb3.1982 |
Ejemplares similares
-
Exploring the role of the Ser9Gly (rs6280) Dopamine D3 receptor polymorphism in nicotine reinforcement and cue-elicited craving
por: Chukwueke, Chidera C., et al.
Publicado: (2020) -
Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
por: Gendy, Marie N. S., et al.
Publicado: (2018) -
Influence of Nicotine Metabolism Ratio on [(11)C]-(+)-PHNO PET Binding in Tobacco Smokers
por: Di Ciano, Patricia, et al.
Publicado: (2018) -
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking
por: Gamaleddin, Islam, et al.
Publicado: (2012) -
High Reinforcing Efficacy of Nicotine in Non-Human Primates
por: Le Foll, Bernard, et al.
Publicado: (2007)